Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Check Note
2000/2000
Ver. Summary Created by Modification Content Size Created at Operation
1 Medical use of secondary metabolites from plants (medicinal and aromatic) will establish secondary metabolites as medicines if the research is based on evidences. Future works could focus on the experiments on in vivo animal models, pre-clinical trials an + 446 word(s) 446 2019-10-23 11:18:22 |
2 format correct Meta information modification 446 2019-10-23 11:53:01 | |
3 format correct Meta information modification 446 2019-10-23 11:54:11 | |
4 format correct Meta information modification 446 2020-10-30 04:25:01 |
Screening of Medicinal Plants
Edit
Upload a video

Secondary metabolites, used as a single compound or as a mixture, are medicines that can be effective and safe even when synthetic drugs fail. They may even potentiate or synergize the effects of other compounds in the medicine. To meet the positive demands, heterologous expression of the genes involved in the biosynthesis of the potent compound will help in the production on the required scale. Further modifications to enhance the ADME properties of the compounds will have a significant advantage in the drug’s biological activities and bioavailability.

Secondary metabolites Medicinal plants Biological activities HPLC Methylation
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 696
Revisions: 4 times (View History)
Update Date: 30 Oct 2020
Table of Contents

    Background

    There has been extensive research on medicinal plants for their use as alternative medicine and nutraceuticals [1][2]. Most of the plants found in nature produce the secondary metabolites (SM) during their stress conditions, and these are essential for their survival (Plant immunity) [3]. Secondary metabolites are compounds other than primary metabolites and are not required for the plant for metabolic functions. SM are composed of phenolic compounds, aromatic compounds, flavonoids, anthraquinones, terpenoids, alkaloids, antibiotics, quinolines etc. to name a few selected important ones [4]. These SM have found to be beneficial to humans and animals as they have demonstrated an array of pharmacological benefits like anti-oxidant, anti-tumor, anti-bacterial, anti-inflammatory, anti-diabetic, anti-allergic, anti-fungal, etc. [5][6].

    In this context, it’s important that we research on medicinal plants having biological activities elucidate their chemical structures along with their commercial-scale production using their biosynthetic gene clusters in a heterologous host. The new discoveries may help us to combat the present hot topic of antibiotic resistance, diabetes, address the cure for cancer and HIV infections, along with many other diseases [7][8].

    Research design

    Plant materials will be collected and the scientific name of the plants will be identified from the concerned authorities. Crushed and powdered plant samples will be either extracted with ethanol, hexane and ethyl acetate or separately scrubbed hydro distilled in a Clevenger-type apparatus to get the oils. The extracts and the oils from the plants will be analyzed using HPLC, LC-MS, GC, and GC-MS to find the compounds present in the sample. Each fraction of extract will be evaluated for biological activities like anti-oxidant potential, anti-cholinesterase activity, anti-inflammatory activity, anti-diabetic activities, etc. The active major component of the fraction will be further processed for structural elucidation using NMR. If we get a novel compound, we may want to do genome sequencing of the plant and obtain the biosynthetic pathways using bioinformatic tools (Genome mining). The pathway may also be introduced in heterologous hosts like E. coli for mass production of the active compounds. Further modifications like glycosylation, methylation, hydroxylation, sulfonation, etc. could be experimented to enhance the ADME properties and bioactivities of the compounds.

     

    References

    1. Aryal, S., Baniya, MK., Danakhu, K., Kuwar, P., Gurung, R., Koirala, N., 2019. Total phenolic, flavonoid content and antioxidant potential of wild vegetables from western Nepal. Plants. 8(4), 96.
    2. Aryal, S., Adhikari, B., Panthi, K., Aryal, P., Mallik, S.K., Bhusal, R.P., Salehi, B., Setzer, W.N., Sharifi-Rad, J., Koirala, N., 2019. Antipyretic, antinociceptive, and anti-inflammatory activities from Pogostemon benghalensis leaf extract in experimental Wister rats.Medicines. 6(4), 96.
    3. Koirala, N., Pandey, R.P., Thuan, N.H., Ghimire, G.P, Jung, H.J, Oh, T.J, Sohng, J.K., 2019. Metabolic engineering of Escherichia coli for the production of isoflavonoid-4՛-O-methoxides and their biological activities. Biotechnol. Appl. Biochem. 66(4), 484-493.
    4. Koirala, N., Thuan, N.H., Ghimire, G.P., Thang, D.V., Sohng, J.K., 2016. Methylation of flavonoids: chemical structures, bioactivities, progress and perspectives for biotechnological production. Enzyme Microb. Technol. 86, 103-116.
    5. Koirala, N., Pandey, R.P., Thang, D.V., Jung, H.J., Sohng, J.K., 2014. Glycosylation and subsequent malonylation of isoflavonoids in E. coli: Strain development, production and insights into future metabolic perspectives. J. Ind. Microbiol. Biotechnol. 41, 1647-1658.
    6. Koirala, N., Pandey, R.P., Parajuli, P., Jung, H.J., Sohng, J.K., 2014. Methylation and subsequent glycosylation of 7,8-dihydroxyflavone. J. Biotech 184, 128-137.
    7. Russo, D., Valentão, P., Andrade, P.B., Fernandez, E., Milella, L., Choi, C.W., 2015. Evaluation of antioxidant, antidiabetic and anticholinesterase activities of Smallanthus sonchifolius Landraces and correlation with their phytochemical profiles. Int. J. Mol. Sci. 16(8), 17696-17718.
    8. Pan, S.Y., Zhou, S.F., Gao, S.H., Yu, Z.L et al., 2013, New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics. Evid.-Based Complementary Altern. Med 627375.
    More
    Information
    Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
    View Times: 696
    Revisions: 4 times (View History)
    Update Date: 30 Oct 2020
    Table of Contents
      1000/1000

      Confirm

      Are you sure to Delete?

      Video Upload Options

      Do you have a full video?
      Cite
      If you have any further questions, please contact Encyclopedia Editorial Office.
      Koirala, N. Screening of Medicinal Plants. Encyclopedia. Available online: https://encyclopedia.pub/entry/121 (accessed on 03 October 2023).
      Koirala N. Screening of Medicinal Plants. Encyclopedia. Available at: https://encyclopedia.pub/entry/121. Accessed October 03, 2023.
      Koirala, Niranjan. "Screening of Medicinal Plants" Encyclopedia, https://encyclopedia.pub/entry/121 (accessed October 03, 2023).
      Koirala, N.(2019, October 23). Screening of Medicinal Plants. In Encyclopedia. https://encyclopedia.pub/entry/121
      Koirala, Niranjan. "Screening of Medicinal Plants." Encyclopedia. Web. 23 October, 2019.